Quality Control and Cost Control Analysis of Pulmonary Tuberculosis Clinical Pathway
DOI:
https://doi.org/10.37287/ijghr.v7i6.422Keywords:
clinical pathway, cost control, pulmonary tuberculosis, quality controlAbstract
Tuberculosis is one of the global health issues discussed at the G20 meeting in 2020 in Indonesia, where the number of pulmonary tuberculosis patients in Indonesia continues to increase, where the treatment of pulmonary tuberculosis patients in hospitals requires clinical pathways to provide effective and efficient services to pulmonary tuberculosis patients in the treatment room. The study was conducted quantitatively with a cross sectional research design conducted on 127 medical record files of pulmonary tuberculosis patients in the inpatient treatment room at RSUD IA Moeis Samarinda in 2024 using purposive sampling. Electronic instruments of patient medical records were used to obtain data on compliance with specialist visits, laboratory examinations, thoracic X-ray examinations, administration of Anti-Tuberculosis Drugs, Length of stay, Cost of Drugs and Consumables (BHP), and Cost of Services to assess the effect of Quality Control and Cost Control of Clinical pathway for pulmonary tuberculosis patients hospitalized at RSUD IA Moeis Samarinda. Multivariate analysis using Kruskal Walls test. The results showed that variables that had an influence on the clinical pathway included compliance with specialist visits, where an increase in compliance with specialist visits was also obtained in the group without clinical pathway on average 57.04%, and the group with clinical pathway amounted to 64.07%. Antituberculosis drug administration also increased, in the group without clinical pathway by 22.6% and in the group with clinical pathway by 44.2%. Other variables that also affect the clinical pathway are Length of stay, Cost of Drugs and BHP, and Cost of Services. While 2 other variables, laboratory examination and radiology examination, did not affect the clinical pathway. The conclusion of this study is that clinical pathway is significantly related to visit compliance, OAT administration, Length of Stay, BHP Costs and Service Costs.
References
Afifah, M., & Nurwahyuni, A. (2024). Analisis implementasi clinical pathway pada pasien demam dengue: Systematic literature review. Syntax Literate: Jurnal Ilmiah Indonesia, 9(1), 45–56. https://doi.org/10.36418/syntax-literate.v9i1.12345
Amioka, N., Takaishi, A., Nakamura, K., Endo, T., Iida, T., Yamaji, T., ... & Momomura, S. (2022). Innovative clinical pathway shortened the length of hospital stay and prevented readmission in patients with acute decompensated heart failure. Journal of Cardiology, 80(3), 237–243. https://doi.org/10.1016/j.jjcc.2022.01.009
Aspland, E., Gartner, D., & Harper, P. (2021). Clinical pathway modelling: A literature review. Health Systems, 10(1), 1–24. https://doi.org/10.1080/20476965.2020.1836721
Badan Pusat Statistik Kota Samarinda. (2021). Kota Samarinda dalam angka: Samarinda municipality figures 2021 (ISSN 0215-2398).
Bagcchi, S. (2023). WHO’s Global Tuberculosis Report 2022. The Lancet Microbe, 4(1). https://doi.org/10.1016/S2666-5247(22)00314-8
Fadilah, N. F. N., & Budi, S. C. (2018). Efektivitas implementasi clinical pathway terhadap average length of stay dan outcomes pasien DF-DHF anak di RSUD Kota Yogyakarta. Jurnal Kesehatan Vokasional, 2(2), 103–111. https://doi.org/10.22146/jkesvo.36419
Firmansyah, H. (2009). Clinical pathway: Integrasi pendokumentasian berbagai disiplin ilmu kesehatan di rumah sakit. Pelayanan Jantung Terpadu RSCM, Fakultas Ilmu Keperawatan Universitas Indonesia, 1(1).
Kementerian Kesehatan Republik Indonesia. (2020). Strategi nasional penanggulangan tuberkulosis di Indonesia 2020–2024. Pertemuan Konsolidasi Nasional Penyusunan STRANAS TB.
Kwon, H., Lee, J. H., Woo, J., Lim, W., Moon, B. I., & Paik, N. S. (2018). Efficacy of a clinical pathway for patients with thyroid cancer. Head & Neck, 40(9), 1870–1876. https://doi.org/10.1002/hed.25166
Murphy, C., French, H., McCarthy, G., & Cunningham, C. (2022). Clinical pathways for the management of low back pain from primary to specialised care: A systematic review. European Spine Journal, 31(5), 1121–1135. https://doi.org/10.1007/s00586-022-07163-4
Rahmawati, C. L., Pinzon, R. T., & Lestari, T. (2017). Evaluasi implementasi clinical pathway appendicitis elektif di RS Bethesda Yogyakarta. Berkala Ilmiah Kedokteran Duta Wacana, 2(3), 45–53.
Sabarguna, B. S. (2022). Clinical pathway for improving quality service and cost containment in hospital. In Contemporary issues in information systems: A global perspective.
Sadli, A. (2021). Rancangan pengembangan aplikasi dokumentasi clinical pathway berbasis web. EXPERT: Jurnal Manajemen Sistem Informasi dan Teknologi, 11(2), 142–149. https://doi.org/10.36448/jmsit.v11i2.2075
Šimec, M., Krsnik, S., & Erjavec, K. (2021). Integrated clinical pathways: Communication and participation in a multidisciplinary team. Open Access Macedonian Journal of Medical Sciences, 9(B), 103–110. https://doi.org/10.3889/oamjms.2021.5815
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indonesian Journal of Global Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
